Edition:
India

People: Zynerba Pharmaceuticals Inc (ZYNE.OQ)

ZYNE.OQ on NASDAQ Stock Exchange Global Market

20.98USD
28 Apr 2017
Change (% chg)

$-0.01 (-0.05%)
Prev Close
$20.99
Open
$20.91
Day's High
$21.34
Day's Low
$20.64
Volume
74,689
Avg. Vol
125,353
52-wk High
$25.95
52-wk Low
$6.02

Hanlon, Suzanne 

Ms. Suzanne M. Hanlon is the Secretary, General Counsel and Vice President - Human Resources of the company. Prior to joining the company, Ms. Hanlon served as legal consultant from May 2014 to October 2014. She has more than 25 years of legal experience in the pharmaceutical industry. She served as vice president, associate general counsel of NuPathe from July 2005 to April 2014. Prior to joining NuPathe, Ms. Hanlon served as chief development counsel of Auxilium, a specialty pharmaceutical company. Prior to joining Auxilium, she served as vice president of global contracts and general counsel at IBAH, Inc. Prior to joining IBAH, Inc., She was a partner at Montgomery McCracken Walker & Rhoads LLP. Ms. Hanlon holds a B.A. from Pennsylvania State University and a J.D. from Villanova University School of Law.

Basic Compensation

Total Annual Compensation, USD 61,538
Restricted Stock Award, USD 96,394
Long-Term Incentive Plans, USD --
All Other, USD 87,107
Fiscal Year Total, USD 245,039

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --